Clinical Trial Update: A Sunscreen Based on Bioadhesive Nanoparticles [Phase 1]

View source ↗

Summary

Phase 1 trial of a sunscreen based on bioadhesive nanoparticles conducted by Yale University has completed, assessing safety and early signals related to UV ski…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Bioadhesive nanoparticle sunscreen

Snippet

Sponsor: Yale University | Conditions: Melanoma, UV Ray Skin Damage | Phase 1 | Status: COMPLETED